Extrathoracic PET/CT findings in thoracic malignancies

J Thorac Imaging. 2006 May;21(2):154-66. doi: 10.1097/00005382-200605000-00007.

Abstract

The routine use of integrated positron emission tomography computed tomography in the staging and follow-up of patients diagnosed with non-small-cell lung cancer has improved diagnostic accuracy but many incidental extrathoracic findings are routinely encountered. These include physiologic fluorodeoxy glucose avid foci, normal computed tomography variants, and second primary malignancies, all of which have to be differentiated from extrathoracic metastatic disease. Knowledge of these findings is important for correct staging and identification of second primaries.

Publication types

  • Review

MeSH terms

  • Adipose Tissue / physiopathology
  • Bone Marrow / diagnostic imaging
  • Bone Marrow / metabolism
  • Brain Neoplasms / diagnostic imaging
  • Brain Neoplasms / secondary
  • Carcinoma, Non-Small-Cell Lung / diagnosis*
  • Carcinoma, Non-Small-Cell Lung / diagnostic imaging
  • Carcinoma, Non-Small-Cell Lung / physiopathology
  • Carcinoma, Non-Small-Cell Lung / secondary
  • Carcinoma, Non-Small-Cell Lung / therapy
  • Glucose-6-Phosphate / analogs & derivatives
  • Head and Neck Neoplasms / diagnostic imaging
  • Humans
  • Lymphatic Metastasis
  • Positron-Emission Tomography / methods*
  • Thoracic Neoplasms / diagnosis*
  • Thoracic Neoplasms / diagnostic imaging
  • Thoracic Neoplasms / pathology
  • Thoracic Neoplasms / physiopathology
  • Thyroid Gland / diagnostic imaging
  • Tomography, X-Ray Computed / methods*
  • Vocal Cord Paralysis / therapy

Substances

  • 2-fluoro-2-deoxyglucose-6-phosphate
  • Glucose-6-Phosphate